BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27490497)

  • 1. NMR-Assisted Molecular Docking Methodologies.
    Sturlese M; Bellanda M; Moro S
    Mol Inform; 2015 Aug; 34(8):513-25. PubMed ID: 27490497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of NMR and molecular docking in structure-based drug discovery.
    Stark JL; Powers R
    Top Curr Chem; 2012; 326():1-34. PubMed ID: 21915777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead Identification Through the Synergistic Action of Biomolecular NMR and In Silico Methodologies.
    Marousis KD; Tsika AC; Birkou M; Matsoukas MT; Spyroulias GA
    Methods Mol Biol; 2018; 1824():299-316. PubMed ID: 30039415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
    Hanzawa H; Shimada T; Takahashi M; Takahashi H
    J Biomol NMR; 2020 Nov; 74(10-11):501-508. PubMed ID: 32306215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR in drug discovery on membrane proteins.
    Wirmer-Bartoschek J; Bartoschek S
    Future Med Chem; 2012 May; 4(7):869-75. PubMed ID: 22571612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of protein-ligand docking with simulated chemical shift perturbations.
    Ten Brink T; Aguirre C; Exner TE; Krimm I
    J Chem Inf Model; 2015 Feb; 55(2):275-83. PubMed ID: 25357133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking: Shifting Paradigms in Drug Discovery.
    Pinzi L; Rastelli G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Frontiers in Druggability.
    Kozakov D; Hall DR; Napoleon RL; Yueh C; Whitty A; Vajda S
    J Med Chem; 2015 Dec; 58(23):9063-88. PubMed ID: 26230724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid protein-ligand costructures using chemical shift perturbations.
    Stark J; Powers R
    J Am Chem Soc; 2008 Jan; 130(2):535-45. PubMed ID: 18088118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated docking for novel drug discovery.
    Bello M; Martínez-Archundia M; Correa-Basurto J
    Expert Opin Drug Discov; 2013 Jul; 8(7):821-34. PubMed ID: 23642085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection.
    Ballante F
    Methods Mol Biol; 2018; 1824():67-88. PubMed ID: 30039402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules.
    Gossert AD; Jahnke W
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():82-125. PubMed ID: 27888841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions in NMR Tubes as Key Weapon in Rational Drug Design.
    Ntountaniotis D
    Methods Mol Biol; 2018; 1824():417-430. PubMed ID: 30039422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential considerations for using protein-ligand structures in drug discovery.
    Warren GL; Do TD; Kelley BP; Nicholls A; Warren SD
    Drug Discov Today; 2012 Dec; 17(23-24):1270-81. PubMed ID: 22728777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yada: a novel tool for molecular docking calculations.
    Piotto S; Di Biasi L; Fino R; Parisi R; Sessa L; Concilio S
    J Comput Aided Mol Des; 2016 Sep; 30(9):753-759. PubMed ID: 27565794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polarization Transfer from Ligands Hyperpolarized by Dissolution Dynamic Nuclear Polarization for Screening in Drug Discovery.
    Min H; Sekar G; Hilty C
    ChemMedChem; 2015 Sep; 10(9):1559-63. PubMed ID: 26315550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Practical Perspective: The Effect of Ligand Conformers on the Negative Image-Based Screening.
    Ahinko M; Kurkinen ST; Niinivehmas SP; Pentikäinen OT; Postila PA
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.